Literature DB >> 25233795

Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women.

B H Yun1, S J Chon, Y J Lee, E J Han, S Cho, Y S Choi, B S Lee, S K Seo.   

Abstract

OBJECTIVE: We investigated the possible association of metabolic syndrome with arterial stiffness and coronary atherosclerosis in non-diabetic, postmenopausal women.
METHODS: A total of 293 non-diabetic, postmenopausal women who visited the health promotion center for a routine health check-up were included in a cross-sectional study. Arterial stiffness was measured by brachial-ankle pulse wave velocity, and coronary atherosclerosis was detected using 64-row multi-detector computed tomography.
RESULTS: Women with coronary atherosclerosis had a significantly higher proportion of metabolic syndrome than those without coronary atherosclerosis. The brachial-ankle pulse wave velocity was significantly higher in women who had metabolic syndrome compared to those who had no metabolic syndrome (1567.71 ± 211.81 vs. 1336.75 ± 159.62 cm/s, p < 0.001). In addition, the brachial-ankle pulse wave velocity was shown to increase with increasing number of metabolic syndrome components (p for trend < 0.001). Metabolic syndrome was associated with increased risk of coronary atherosclerosis (adjusted odds ratio 2.38; 95% confidence interval 1.01-5.06), after adjusting for confounding factors.
CONCLUSIONS: Metabolic syndrome increases the risk of coronary atherosclerosis in postmenopausal women. Increased arterial stiffness may partly explain an increased risk of coronary atherosclerosis in postmenopausal women with metabolic syndrome.

Entities:  

Keywords:  ARTERIAL STIFFNESS; CORONARY ATHEROSCLEROSIS; METABOLIC SYNDROME; POSTMENOPAUSAL WOMEN

Mesh:

Substances:

Year:  2014        PMID: 25233795     DOI: 10.3109/13697137.2014.960384

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  3 in total

1.  Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs.

Authors:  Wennan Li; Xingjuan Chen; Ashley M Riley; S Christopher Hiett; Constance J Temm; Eleni Beli; Xin Long; Saikat Chakraborty; Mouhamad Alloosh; Fletcher A White; Maria B Grant; Michael Sturek; Alexander G Obukhov
Journal:  Basic Res Cardiol       Date:  2017-07-29       Impact factor: 17.165

2.  Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women.

Authors:  Bo Hyon Yun; Seung Joo Chon; Si Hyun Cho; Young Sik Choi; Byung Seok Lee; Seok Kyo Seo
Journal:  J Menopausal Med       Date:  2016-12-31

3.  Astragalus Membranaceus Improving Asymptomatic Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertensive Women with Metabolic Syndrome: A Prospective, Open-Labeled, Randomized Controlled Trial.

Authors:  Ning-Yin Li; Heng Yu; Xiu-Li Li; Qiong-Ying Wang; Xiao-Wei Zhang; Rui-Xin Ma; Yang Zhao; Han Xu; Wei Liang; Feng Bai; Jing Yu
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.